Published in Cancer Biol Ther on March 20, 2010
Anticancer activity of metal complexes: involvement of redox processes. Antioxid Redox Signal (2011) 1.32
Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP. Nucleic Acids Res (2012) 0.94
Gene expression profiling of NB4 cells following knockdown of nucleostemin using DNA microarrays. Mol Med Rep (2016) 0.75
Cancer-related inflammation. Nature (2008) 34.21
Nuclear factor-kappaB in cancer development and progression. Nature (2006) 18.31
Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res (1999) 10.65
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science (2004) 10.23
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature (2009) 6.99
Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell (2007) 5.09
TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev (2002) 4.66
NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev (2008) 4.61
5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments. Mol Cell Biol (2006) 4.28
Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med (2001) 3.87
Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol (2000) 2.59
Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res (2003) 1.94
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer. Clin Cancer Res (2008) 1.88
The transcription factor MTF-1 mediates metal regulation of the mouse ZnT1 gene. J Biol Chem (2000) 1.70
Embryonic lethality and liver degeneration in mice lacking the metal-responsive transcriptional activator MTF-1. EMBO J (1998) 1.61
Zinc metallothionein imported into liver mitochondria modulates respiration. Proc Natl Acad Sci U S A (2001) 1.46
Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res (2001) 1.42
Development of novel therapeutic strategies that target HIF-1. Expert Opin Ther Targets (2006) 1.38
ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells. Endocrinology (2008) 1.38
Putting its fingers on stressful situations: the heavy metal-regulatory transcription factor MTF-1. Bioessays (2001) 1.33
Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis (2002) 1.32
Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione. Nucleic Acids Res (2005) 1.30
Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1). Arch Biochem Biophys (2007) 1.20
Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1. Cancer Res (1999) 1.18
Target gene search for the metal-responsive transcription factor MTF-1. Nucleic Acids Res (2001) 1.16
Regulation of metallothionein transcription by the metal-responsive transcription factor MTF-1: identification of signal transduction cascades that control metal-inducible transcription. J Biol Chem (2002) 1.14
Zinc-induced formation of a coactivator complex containing the zinc-sensing transcription factor MTF-1, p300/CBP, and Sp1. Mol Cell Biol (2008) 1.11
NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells. Biol Chem (2005) 1.06
Regulation of ZIP and ZnT zinc transporters in zebrafish gill: zinc repression of ZIP10 transcription by an intronic MRE cluster. Physiol Genomics (2008) 1.04
Metal-responsive transcription factor-1 (MTF-1) is essential for embryonic liver development and heavy metal detoxification in the adult liver. FASEB J (2004) 1.04
Phosphorylation is involved in the activation of metal-regulatory transcription factor 1 in response to metal ions. J Biol Chem (2001) 1.04
Ribosomal protein S25 mRNA partners with MTF-1 and La to provide a p53-mediated mechanism for survival or death. J Biol Chem (2001) 1.02
Zinc accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors is accompanied by an altered expression of ZnT-1 and metallothionein. Exp Biol Med (Maywood) (2003) 1.01
Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1. J Biol Chem (2008) 1.01
Metal-responsive transcription factor-1 (MTF-1) selects different types of metal response elements at low vs. high zinc concentration. Biol Chem (2004) 0.99
Metallothionein in radiation exposure: its induction and protective role. Toxicology (1999) 0.98
Metallothionein induction by hypoxia involves cooperative interactions between metal-responsive transcription factor-1 and hypoxia-inducible transcription factor-1alpha. Mol Cancer Res (2008) 0.96
Induction of metallothionein I by arsenic via metal-activated transcription factor 1: critical role of C-terminal cysteine residues in arsenic sensing. J Biol Chem (2009) 0.95
Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts. Mol Cancer Ther (2007) 0.94
Nitric oxide-induced nuclear translocation of the metal responsive transcription factor, MTF-1 is mediated by zinc release from metallothionein. Vascul Pharmacol (2006) 0.94
The metal-responsive transcription factor-1 contributes to HIF-1 activation during hypoxic stress. Biochem Biophys Res Commun (2005) 0.92
Inhibition of hypoxia/reoxygenation-induced apoptosis in metallothionein-overexpressing cardiomyocytes. Am J Physiol Heart Circ Physiol (2001) 0.91
Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice. Am J Pathol (2003) 0.89
Elevated metallothionein (MT) expression in invasive ductal breast cancers predicts tamoxifen resistance. Histol Histopathol (2005) 0.86
Metallothionein as a prognostic biomarker in breast cancer. Exp Biol Med (Maywood) (2006) 0.85
The heavy metal-responsive transcription factor-1 (MTF-1) is not required for neural differentiation. Biol Chem (1999) 0.84
Zinc-metallothionein protects from DNA damage induced by radiation better than glutathione and copper- or cadmium-metallothioneins. Toxicol Lett (2003) 0.83
Loss of metal transcription factor-1 suppresses tumor growth through enhanced matrix deposition. FASEB J (2004) 0.83
Characterization of the mouse gene for the heavy metal-responsive transcription factor MTF-1. Cell Stress Chaperones (2000) 0.80
Regulation of malignant progression by the hypoxia-sensitive transcription factors HIF-1alpha and MTF-1. Comp Biochem Physiol B Biochem Mol Biol (2004) 0.80
MRE-binding transcription factor-1 is activated during endotoxemia: a central role for metallothionein. Toxicol Lett (2002) 0.80
Chromium(VI) inhibits mouse metallothionein-I gene transcription by preventing the zinc-dependent formation of an MTF-1-p300 complex. Biochem J (2008) 0.79
Role of metal-responsive transcription factor-1 (MTF-1) in EGF-dependent DNA synthesis in primary hepatocytes. J Cell Biochem (2006) 0.77
Protection from radiation-induced DNA single-strand breaks by induction of nuclear metallothionein. Int J Radiat Biol (2000) 0.76
A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59
5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments. Mol Cell Biol (2006) 4.28
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol (2007) 3.93
Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol Imaging (2004) 3.40
Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol (2003) 1.63
SU5416 delays wound healing through inhibition of TGF-beta 1 activation. Cancer Biol Ther (2002) 1.58
A novel peroxisome proliferator-activated receptor delta antagonist, SR13904, has anti-proliferative activity in human cancer cells. Cancer Biol Ther (2009) 1.47
A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol (2003) 1.26
Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824. Cancer Res (2004) 1.24
Functional significance of erythropoietin receptor expression in breast cancer. Lab Invest (2002) 1.23
Molecular mechanism of convergent regulation of brain Na(+) channels by protein kinase C and protein kinase A anchored to AKAP-15. Mol Cell Neurosci (2002) 1.10
The relationship between hypoxia and angiogenesis. Semin Radiat Oncol (2004) 1.07
NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells. Biol Chem (2005) 1.06
Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling. J Med Chem (2007) 1.05
Expression of erythropoietin receptor splice variants in human cancer. Biochem Biophys Res Commun (2003) 1.00
Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies. J Neurochem (2004) 0.99
Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia. Clin Cancer Res (2005) 0.98
PXR and the regulation of apoA1 and HDL-cholesterol in rodents. Pharmacol Res (2004) 0.98
Metallothionein induction by hypoxia involves cooperative interactions between metal-responsive transcription factor-1 and hypoxia-inducible transcription factor-1alpha. Mol Cancer Res (2008) 0.96
Particle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity. Nano Lett (2014) 0.93
Hemopressin forms self-assembled fibrillar nanostructures under physiologically relevant conditions. Biomacromolecules (2012) 0.93
Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice. Urology (2002) 0.92
The metal-responsive transcription factor-1 contributes to HIF-1 activation during hypoxic stress. Biochem Biophys Res Commun (2005) 0.92
Erythropoietin and erythropoietin receptor expression in human prostate cancer. Mod Pathol (2005) 0.88
Pathway logic: symbolic analysis of biological signaling. Pac Symp Biocomput (2002) 0.88
Inspiratory contrast for in vivo optical imaging. Opt Express (2008) 0.86
Binding of discoidin domain receptor 2 to collagen I: an atomic force microscopy investigation. Biochemistry (2002) 0.86
Enhanced gastrointestinal motility with orally active ghrelin receptor agonists. J Pharmacol Exp Ther (2009) 0.85
A novel steroidal inhibitor of estrogen-related receptor alpha (ERR alpha). Biochem Pharmacol (2010) 0.84
Increase in tissue inhibitor of metalloproteinase-2 (TIMP-2) levels and inhibition of MMP-2 activity in a metastatic breast cancer cell line by an anti-invasive small molecule SR13179. Cancer Lett (2009) 0.83
Central G-Protein Coupled Receptors (GPCR)s as molecular targets for the treatment of obesity: assets, liabilities and development status. Curr Drug Targets CNS Neurol Disord (2004) 0.83
Loss of metal transcription factor-1 suppresses tumor growth through enhanced matrix deposition. FASEB J (2004) 0.83
Magnetic resonance imaging measurement of the contralateral normal meniscus is a more accurate method of determining meniscal allograft size than radiographic measurement of the recipient tibial plateau. Arthroscopy (2007) 0.83
Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin. Clin Cancer Res (2003) 0.83
Body weight regulation by selective MC4 receptor agonists and antagonists. Ann N Y Acad Sci (2003) 0.82
Wound healing monitoring using near infrared fluorescent fibrinogen. Biomed Opt Express (2010) 0.81
Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180). J Med Chem (2007) 0.79
SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo. Angiogenesis (2010) 0.78
The rational design of a novel potent analogue of the 5'-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular activity. Bioorg Med Chem Lett (2010) 0.78
Isosteric N-arylpiperazine replacements in a series of dihydropyridine NPY1 receptor antagonists. Bioorg Med Chem Lett (2004) 0.77
Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidate. J Med Chem (2014) 0.76
The WHO STEPwise Approach to Stroke Surveillance. J Coll Physicians Surg Pak (2008) 0.76
Dietary glycine inhibits angiogenesis during wound healing and tumor growth. Cancer Biol Ther (2003) 0.76
Antitumor efficacy and molecular mechanism of TLK58747, a novel DNA-alkylating prodrug. Anticancer Res (2009) 0.76
Changes to NIH grant system may backfire. Science (2008) 0.75
Whole-Slide Imaging of Pap Cellblock Preparations Is a Potentially Valid Screening Method. Acta Cytol (2015) 0.75
Utilization of an active site mutant receptor for the identification of potent and selective atypical 5-HT2C receptor agonists. J Med Chem (2017) 0.75
Tetrazole based amides as growth hormone secretagogues. Bioorg Med Chem Lett (2008) 0.75
Discovery and optimization of (R)-prolinol-derived agonists of the Growth Hormone Secretagogue receptor (GHSR). Bioorg Med Chem Lett (2008) 0.75
Tetrahydroisoquinoline 1-carboxamides as growth hormone secretagogues. Bioorg Med Chem Lett (2005) 0.75
Acute Exacerbation of Interstitial Lung Disease After Cryobiopsy. J Bronchology Interv Pulmonol (2017) 0.75
Partial peroneus longus tendon rupture in professional basketball players: a report of 2 cases. Am J Orthop (Belle Mead NJ) (2002) 0.75
(D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues. Bioorg Med Chem Lett (2008) 0.75
Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues. Bioorg Med Chem Lett (2008) 0.75
Reductions in log P improved protein binding and clearance predictions enabling the prospective design of cannabinoid receptor (CB1) antagonists with desired pharmacokinetic properties. J Med Chem (2013) 0.75
Discovery, synthesis, and structure-activity studies of tetrazole based growth hormone secretagogues. Bioorg Med Chem Lett (2007) 0.75
Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chain. Bioorg Med Chem Lett (2008) 0.75